Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals
Financial Results:
Tatva Chintan Pharma Chem Ltd reported Revenues for Q3FY24 of ₹84.21 Crores down from ₹120.61 Crore year on year, a fall of 30.18%.
Total Expenses for Q3FY24 of ₹80.17 Crores down from ₹107.46 Crores year on year, a fall of 25.4%.
Consolidated Net Profit of ₹3.46 Crores down 70.22% from ₹11.62 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.48, down 71.76% from ₹5.24 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.